LA-Bac8c
LA-Bac8c is a Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. LA-Bac8c inhibits S. aureus, MRSA, S. epidermidis, E. coli, and P. aeruginosa with MICs of 1, 4, 8, 8, and 8 μg/mL[1].
Product Specifications
UNSPSC
12352209
Target
Antibiotic; Bacterial
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/la-bac8c.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](NC(CCCC[C@@H]1CCSS1)=O)CCCNC(N)=N)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CC2=CNC3=CC=CC=C23)=O)[C@H](CC)C)=O)C(C)C)=O)CC4=CNC5=CC=CC=C45)=O)[C@H](CC)C
Molecular Formula
C65H102N20O9S2
Molecular Weight
1371.76
References & Citations
[1]Wenya Zhou, et al. Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. Bioorg Med Chem. 2020 Oct 1;28 (19) :115682.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
